Gender specific medicine in liver diseases: A point of view

World Journal of Gastroenterology

Volumn 20, Issue 9, 2014, Pages 2127-2135

  Durazzo, Marilena ^a   Belci, Paola ^a   Collo, Alessandro ^a   Prandi, Vanessa ^a   Pistone, Erika ^a   Martorana, Maria ^a   Gambino, Roberto ^a   Bo, Simona ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Alcoholic liver disease; Autoimmune hepatitis; Gender; Liver disease; Non alcoholic fatty liver disease; Primary biliary cirrhosis; Viral chronic hepatitis B; Viral chronic hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL DEHYDROGENASE; ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5;

ALCOHOL LIVER DISEASE; AUTOIMMUNE HEPATITIS; CD4+ T LYMPHOCYTE; CELL MATURATION; CYTOLYSIS; DISEASE COURSE; GENDER; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; INCIDENCE; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; RISK FACTOR; SEX CHROMOSOME; SEX DIFFERENCE; ATTITUDE TO HEALTH; CHRONIC DISEASE; FEMALE; HEALTH BEHAVIOR; HEALTH DISPARITY; LIFESTYLE; LIVER DISEASES; MALE; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PREGNANCY; PROGNOSIS; PROTECTION; PSYCHOLOGY;

CHRONIC DISEASE; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS DISPARITIES; HUMANS; INDIVIDUALIZED MEDICINE; LIFE STYLE; LIVER DISEASES; MALE; PREGNANCY; PROGNOSIS; PROTECTIVE FACTORS; RISK FACTORS; SEX FACTORS;

EID: 84895887588     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i9.2127     Document Type: Review

References (91)

1. Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V. Gender medicine: a task for the third millennium. Clin Chem Lab Med 2013; 51: 713-727 [PMID: 23515103 DOI: 10.1515/ cclm-2012-0849]
2. Floreani A, Cazzagon N, Boemo DG, Baldovin T, Baldo V, Egoue J, Antoniazzi S, Minola E. Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. Eur J Gastroenterol Hepatol 2011; 23: 997-1003 [PMID: 21915057 DOI: 10.1097/MEG.0b013e32834ae863]
3. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995; 1: 1279-1283 [PMID: 7489409 DOI: 10.1038/nm1295-1279]
4. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158: 446-451 [PMID: 8977221]
5. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991; 78: 688-699 [PMID: 1830499]
6. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273 [PMID: 16177252 DOI: 10.1056/NEJMra043898]
7. Hohenester S, Oude-Elferink RP, Beuers U. Primary biliary cirrhosis. Semin Immunopathol 2009; 31: 283-307 [PMID: 19603170 DOI: 10.1007/s00281-009-0164-5]
8. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350: 875-879 [PMID: 9310614 DOI: 10.1016/S0140-6736(97)05419-6]
9. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th ed. Oxford: Blackwell Sci Pub, 2002: 241-253
10. Nalbandian G, Van de Water J, Gish R, Manns M, Coppel RL, Rudich SM, Prindiville T, Gershwin ME. Is there a serological difference between men and women with primary biliary cirrhosis? Am J Gastroenterol 1999; 94: 2482-2486 [PMID: 10484012]
11. Kim WR, Lindor KD, Locke GR, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000; 119: 1631-1636 [PMID: 11113084 DOI: 10.1053/gast.2000.20197]
12. Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 2012; 11: A531-A537 [PMID: 22155196 DOI: 10.1016/ j.autrev.2011.11.024]
13. Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, Selmi C, Watnik M, Gershwin ME, Podda M. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004; 363: 533-535 [PMID: 14975617 DOI: 10.1016/S0140-6736(04)15541-4]
14. Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, Watnik M, Grati FR, Simoni G, Gershwin ME, Podda M. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005; 175: 575-578 [PMID: 15972694]
15. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, Gordon SC, Wright HI, Zweiban B, Podda M, Gershwin ME. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485-492 [PMID: 15300581 DOI: 10.1053/ j.gastro.2004.05.005]
16. Lleo A, Oertelt-Prigione S, Bianchi I, Caliari L, Finelli P, Miozzo M, Lazzari R, Floreani A, Donato F, Colombo M, Gershwin ME, Podda M, Invernizzi P. Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun 2013; 41: 87-91 [PMID: 23375847 DOI: 10.1016/ j.jaut.2012.12.008]
17. Rubel LR, Rabin L, Seeff LB, Licht H, Cuccherini BA. Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology 1984; 4: 671-677 [PMID: 6745856 DOI: 10.1002/hep.1840040418]
18. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006; 44: 91-98 [PMID: 16800007 DOI: 10.1002/hep.21230]
19. Newton JL, Hudson M, Tachtatzis P, Sutcliffe K, Pairman J, Burt JA, Jones DE. Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology 2007; 45: 1496-1505 [PMID: 17538969 DOI: 10.1002/hep.21609]
20. Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in men. Gut 1986; 27: 1373-1376 [PMID: 3792920 DOI: 10.1136/gut.27.11.1373]
21. Muratori P, Granito A, Pappas G, Muratori L, Quarneti C, De Molo C, Cipriano V, Vukotic R, Andreone P, Lenzi M, Bianchi FB. Clinical and serological profile of primary biliary cirrhosis in men. QJM 2007; 100: 534-535 [PMID: 17609225 DOI: 10.1093/qjmed/hcm059]
22. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938 [PMID: 10580593 DOI: 10.1016/ S0168-8278(99)80297-9]
23. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213 [PMID: 20513004 DOI: 10.1002/hep.23584]
24. Miyake Y, Iwasaki Y, Sakaguchi K, Shiratori Y. Clinical features of Japanese male patients with type 1 autoimmune hepatitis. Aliment Pharmacol Ther 2006; 24: 519-523 [PMID: 16886918 DOI: 10.1111/j.1365-2036.2006.03013.x]
25. Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008; 48: 140-147 [PMID: 18023911 DOI: 10.1016/ j.jhep.2007.08.013]
26. Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002; 97: 3160-3165 [PMID: 12492204 DOI: 10.1111/j.1572-0241.2002.07124.x]
27. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-780 [PMID: 11526384 DOI: 10.1038/ ni0901-777]
28. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, Mac-Carty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-436 [PMID: 2777204 DOI: 10.1002/hep.1840100406]
29. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369 [PMID: 14598252 DOI: 10.1016/j.gastro.2003.07.011]
30. Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, Kaplan GG. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 2011; 53: 1590-1599 [PMID: 21351115 DOI: 10.1002/ hep.24247]
31. Pollheimer MJ, Halilbasic E, Fickert P, Trauner M. Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2011; 25: 727-739 [PMID: 22117638 DOI: 10.1016/j.bpg.2011.10.009]
32. Nagoshi S. Sex-or gender-specific medicine in hepatology. Hepatol Res 2008; 38: 219-224 [PMID: 18047583 DOI: 10.1111/ j.1872-034X.2007.00301.x]
33. Lelbach WK. Quantitative aspects of drinking in alcoholic liver cirrhosis. In: Khanna JM, Israel Y, Kalant H, editors. Alcoholic liver pathology. Alcoholism and drug addiction research foundation of Ontario, Canada. Toronto: Blackwell Publishing, 1975
34. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 1975; 252: 85-105 [PMID: 1096716 DOI: 10.1111/j.1749-6632.1975.tb19146.x]
35. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99 [PMID: 2248624 DOI: 10.1056/NEJM199001113220205]
36. Mancinelli R, Guiducci MS. [Women and alcohol: biological vulnerability]. Ann Ist Super Sanita 2004; 40: 19-23 [PMID: 15269448]
37. Thomasson HR. Gender differences in alcohol metabolism. Physiological responses to ethanol. Recent Dev Alcohol 1995; 12: 163-179 [PMID: 7624539]
38. Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010; 11: 430-445 [PMID: 19845871 DOI: 10.1111/j.1467-789X.2009.00657.x]
39. Farrell GC, Hall P, George J, McCullough AJ, editors. Fatty Liver Disease: NASH and Related Disorders. Malden, MA: Blackwell, 2005: 181-193
40. Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y, Takeda R. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 1992; 27: 521-528 [PMID: 1526433]
41. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304 [PMID: 16123508 DOI: 10.2337/diacare.28.9.2289]
42. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006; 47: 1588-1594 [PMID: 16630995 DOI: 10.1016/j.jacc.2005.11.074]
43. Floreani A, Variola A, Niro G, Premoli A, Baldo V, Gambino R, Musso G, Cassader M, Bo S, Ferrara F, Caroli D, Rizzotto ER, Durazzo M. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol 2008; 103: 1959-1965 [PMID: 18564121 DOI: 10.1111/j.1572-0241.2008.01888.x]
44. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006; 95: 136-147 [PMID: 16598526 DOI: 10.1007/s00392-006-0351-5]
45. Shen W, Punyanitya M, Silva AM, Chen J, Gallagher D, Sardinha LB, Allison DB, Heymsfield SB. Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study. Nutr Metab (Lond) 2009; 6: 17 [PMID: 19371437 DOI: 10.1186/1743-7075-6-17]
46. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, Shimomura I, Tarui S, Matsuzawa Y. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994; 18: 207-202 [PMID: 8044194]
47. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728 [PMID: 16287793 DOI: 10.7326/0003-4819-143-10-200511150-00009]
48. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861-867 [PMID: 19293782 DOI: 10.1038/ajg.2009.67]
49. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112 [PMID: 16447287 DOI: 10.1002/hep.20973]
50. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-1123 [PMID: 10833486 DOI: 10.1016/S0016-5085(00)70364-7]
51. Daryani NE, Daryani NE, Alavian SM, Zare A, Fereshtehnejad SM, Keramati MR, Pashaei MR, Habibollahi P. Nonalcoholic steatohepatitis and influence of age and gender on histopathologic findings. World J Gastroenterol 2010; 16: 4169-4175 [PMID: 20806434 DOI: 10.3748/wjg.v16.i33.4169]
52. Völzke H, Schwarz S, Baumeister SE, Wallaschofski H, Schwahn C, Grabe HJ, Kohlmann T, John U, Dören M. Menopausal status and hepatic steatosis in a general female population. Gut 2007; 56: 594-595 [PMID: 17369390 DOI: 10.1136/gut.2006.115345]
53. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A. What are the risk factors and settings for nonalcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 2007; 22: 794-800 [PMID: 17498218 DOI: 10.1111/ j.1440-1746.2007.04952.x]
54. Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A. Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues. J Viral Hepat 2013; 20: 502-509 [PMID: 23730844 DOI: 10.1111/jvh.12054]
55. Invernizzi P. Isegreti del cromosoma X. Humanitas 2009; 2: 14-15
56. Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl 2008; 14: 1081-1091 [PMID: 18668664 DOI: 10.1002/lt.21572]
57. Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJ, Williams R. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991; 12: 241-245 [PMID: 2051003 DOI: 10.1016/0168-8278(9 1)90945-8]
58. Bozkaya H, Bozdayi M, Türkyilmaz R, Sarioglu M, Cetinkaya H, Cinar K, Köse K, Yurdaydin C, Uzunalimoglu O. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 2000; 47: 1675-1679 [PMID: 11149030]
59. Luppi P, Haluszczak C, Trucco M, Deloia JA. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 2002; 47: 72-81 [PMID: 11900591]
60. Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int 2010; 30: 275-283 [PMID: 19874491 DOI: 10.1111/j.1478-3231.2009.02153. x]
61. ter Borg MJ, Leemans WF, de Man RA, Janssen HL. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008; 15: 37-41 [PMID: 18088243]
62. Tan HH, Lui HF, Chow WC. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int 2008; 2: 370-375 [PMID: 19669267 DOI: 10.1007/s12072-008-9063-4]
63. Nguyen G, Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH. Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther 2009; 29: 755-764 [PMID: 19183158 DOI: 10.1111/j.1365-2036.2009.03932.x]
64. Kumar A. Hepatitis B virus infection and pregnancy: a practical approach. Indian J Gastroenterol 2012; 31: 43-54 [PMID: 22528342 DOI: 10.1007/s12664-012-0174-4]
65. Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastroenterol Clin North Am 2011; 40: 355-72, viii [PMID: 21601784 DOI: 10.1016/j.gtc.2011.03.005]
66. Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol 1980; 87: 958-965 [PMID: 7437368 DOI: 10.1111/j.1471-0528.1980.tb04458.x]
67. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10: 3215-3217 [PMID: 15457579]
68. Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, Yao J, Dong H, Jiang M. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13: 597-604 [PMID: 16907846 DOI: 10.1111/j.1365-2893.2006.00738.x]
69. Beasley RP, Hwang LY, Lin CC, Stevens CE, Wang KY, Sun TS, Hsieh FJ, Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet 1981; 2: 388-393 [PMID: 6115159 DOI: 10.1016/S0140-6736(81)90832-1]
70. Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS, Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983; 3: 135-141 [PMID: 6339349 DOI: 10.1002/hep.1840030201]
71. Yi W, Liu M, Cai HD. Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. World J Gastroenterol 2012; 18: 6645-6650 [PMID: 23236240 DOI: 10.3748/wjg.v18. i45.6645.]
72. Koh M, Shinohara J, Hongo Y, Okazaki T, Takitani K, Tamai H. Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy. Hepatol Res 2013; 43: 425-429 [PMID: 23560863 DOI: 10.1111/j.1872-034X.2012.01077.x]
73. Deng M, Zhou X, Gao S, Yang SG, Wang B, Chen HZ, Ruan B. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virol J 2012; 9: 185 [PMID: 22947333 DOI: 10.1186/1743-422X-9-185]
74. Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antivir Ther 2011; 16: 621-628 [PMID: 21817183 DOI: 10.3851/IMP1813]
75. Zahran KM, Badary MS, Agban MN, Abdel Aziz NH. Pattern of hepatitis virus infection among pregnant women and their newborns at the Women's Health Center of Assiut University, Upper Egypt. Int J Gynaecol Obstet 2010; 111: 171-174 [PMID: 20708181 DOI: 10.1016/j.ijgo.2010.06.013]
76. Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29 Suppl 1: 74-81 [PMID: 19207969 DOI: 10.1111/ j.1478-3231.2008.01934.x]
77. Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Freire FC, Cardoso JR, Bordin JO, Silva AE, Ferraz ML. Anti-hepatitis C virus-positive blood donors: are women any different? Transfus Med 2008; 18: 175-183 [PMID: 18598280 DOI: 10.1111/j.1365-3148.2008.00859.x]
78. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004; 40: 1426-1433 [PMID: 15565616 DOI: 10.1002/hep.20463]
79. Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment? J Viral Hepat 2011; 18: 229-236 [PMID: 21392169 DOI: 10.1111/j.1365-2893.2010.01413.x]
80. Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis 2012; 55 Suppl 1: S3-S9 [PMID: 22715211 DOI: 10.1093/ cid/cis393]
81. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751-755 [PMID: 10706568 DOI: 10.1002/hep.510310328]
82. Pergam SA, Wang CC, Gardella CM, Sandison TG, Phipps WT, Hawes SE. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008; 199: 38. e1-38. e9 [PMID: 18486089]
83. Hayashida A, Inaba N, Oshima K, Nishikawa M, Shoda A, Hayashida S, Negishi M, Inaba F, Inaba M, Fukasawa I, Watanabe H, Takamizawa H. Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies. J Obstet Gynaecol Res 2007; 33: 417-422 [PMID: 17688606 DOI: 10.1111/j.1447-0756.2007.00582.x]
84. Azzari C, Moriondo M, Indolfi G, Betti L, Gambineri E, de Martino M, Resti M. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol 2008; 80: 65-71 [PMID: 18041020 DOI: 10.1002/jmv.21023]
85. Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis 2007; 44: 1123-1131 [PMID: 17366462 DOI: 10.1086/512815]
86. McHutchison JG, Manns MP, Muir AJ, Terrault NA, Jacobson IM, Afdhal NH, Heathcote EJ, Zeuzem S, Reesink HW, Garg J, Bsharat M, George S, Kauffman RS, Adda N, Di Bisceglie AM. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010; 362: 1292-1303 [PMID: 20375406 DOI: 10.1056/NEJMoa0908014]
87. Roberts SS, Miller RK, Jones JK, Lindsay KL, Greene MF, Maddrey WC, Williams IT, Liu J, Spiegel RJ. The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol 2010; 88: 551-559 [PMID: 20564430 DOI: 10.1002/bdra.20682]
88. Fleming RE, Britton RS, Waheed A, Sly WS, Bacon BR. Pathogenesis of hereditary hemochromatosis. Clin Liver Dis 2004; 8: 755-773, vii [PMID: 15464654 DOI: 10.1016/ j.cld.2004.06.004]
89. Eijkelkamp EJ, Yapp TR, Powell LW. HFE-associated hereditary hemochromatosis. Can J Gastroenterol 2000; 14: 121-125 [PMID: 10694284]
90. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997; 127: 105-110 [PMID: 9229998 DOI: 10.7326/0003-4819-127-2-199707150-0 0002]
91. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-166 [PMID: 8985284 DOI: 10.1002/hep.510250130]